Eli Lilly & Co. v Teva Parenteral Meds., Inc. (Fed. Cir. No.: 15-2067); January 12, 2017 CAFC Opinion PDF The Federal Circuit affirmed the District Court’s finding that Teva is liable for induced infringement of Eli Lilly’s US Patent No. 7,772,209 claiming methods for administering Pemetrexed. The Federal Circuit addressed the issue of induced infringement and direct infringement … Continue reading Teva Liable for Induced Infringement of Eli Lilly’s Methods of Administering Pemetrexed (ALIMTA®)